Change in the activity of the lymphocytes in chronic liver diseases treated with prednisolone
Zolotnitskaia, R.P.; Podymova, S.D.; Plotnikova, N.M.; Zozulia, T.V.
Klinicheskaia Meditsina 56(6): 51-55
1978
ISSN/ISBN: 0023-2149 PMID: 672161 Document Number: 135838
Document emailed within 1 workday
Related Documents
Loginow, A.S. 1970: Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 30(1): 19-23Bliuger, A.F.; Veksler, K.M.; Gichev, I.P.; Timoshenko, Z.P.; Soloveĭ, D.I. 1976: Immunocompetence of lymphocytes in viral hepatitis and chronic diseases of the liver Sovetskaia Meditsina 7: 83-87
Shastin, N.N.; Vilenchuk, R.E. 1976: Change in serotonin metabolism in chronic liver diseases Terapevticheskii Arkhiv 48(3): 56-59
Bauch, K.; Büttner, W.; Lewicki, I.; Zimmermann, S.; Dempe, A. 1973: Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(11 Suppl): 169-172
Paronetto, F.; Vernace, S. 1975: Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture Clinical and Experimental Immunology 19(1): 99-104
Gaskina, T.K.; Dolgov, A.V.; Kurilovich, S.A. 1987: Lecithin-cholesterol-acyltransferase activity in chronic liver diseases Voprosy Meditsinskoi Khimii 33(4): 96-99
Yeh, T.L. 1977: Prednisone and prednisolone in chronic active liver disease American Journal of Hospital Pharmacy 34(9): 920; 922
Schnabel, R.; Dalmi, L.; Sipka, S.; Bokor, M.; Malatinszky, G.; Garam, T. 1991: Autoantibody against liver cell membrane and killer cell activity in chronic liver diseases Acta Medica Hungarica 48(1-2): 23-31
Leonova, V.N. 1971: Changes in the glucocorticoid function of the adrenal cortex in patients with chronic lympholeukemia treated with prednisolone and Nerobol Problemy Gematologii i Perelivaniia Krovi 16(9): 55-57
Loginov, A.S.; Isakova, Z.S.; Skobeleva, T.V.; Kartashova, N.A. 1989: 5'-nucleotidase activity in the blood in chronic diseases of the liver and biliary tract Sovetskaia Meditsina 1: 10-12
Hahn, O.; Fricke, R.J.; Hoffmann-Blume, E.; Predel, K. 1974: The significance of collagen peptidase activity determination in the differential diagnosis of chronic liver diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 29(8): 327-331
Schalm, S.W.; Summerskill, W.H.; Go, V.L. 1977: Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone Gastroenterology 72(5 Part 1): 910-913
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Aleshkin, V.A.; Astakhin, A.V.; Afanas'ev, S.S.; Levitan, B.N.; Chishieva, E.M.; Afanas'ev, D.S.; Denisov, L.A.; Afanas'ev, M.S. 2002: Diagnostic and prognostic significance of characteristics of serum interferon antiviral activity in chronic and acute diffuse liver diseases Klinicheskaia Laboratornaia Diagnostika 8: 48-50
Pár, A.; Paál, M.; Kádas, I.; Kerekes, E.; Jávor, T. 1983: Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study) Acta Medica Hungarica 40(1): 17-24
Chernoiarova, O.D.; Loginov, A.S.; Sadokov, V.M. 1983: Change in the trypsin-binding activity of alpha 2-macroglobulin and the general antitrypsin activity of the blood in chronic pancreatitis Klinicheskaia Meditsina 61(11): 88-91
Sueblinvong, T.; Pamutha, P. 2003: Apoptotic activity in lymphocytes from radiation-treated cervical cancer patients Journal of the Medical Association of Thailand 86(2): 157-165
Car, H.; Oksztel, R.; Nadlewska, A.; Wiśniewski, K. 2001: NMDA receptor antagonists change behavioral activity of rats treated with (S)-4CPG Polish Journal of Pharmacology 53(4): 331-339
Toda, G.; Ikeda, Y.; Hashimoto, N.; Yamazaki, M.; Torii, M.; Oka, H. 1983: Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases Clinical and Experimental Immunology 54(3): 661-670
Obayashi, A.; Akioka, H.; Tazaki, H. 1972: Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases Arzneimittel-Forschung 22(3): 578-580